Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Surgical Approach with Oncologic Outcomes in Low-Risk Cervical Cancer.

American journal of obstetrics and gynecology·2026
Same author

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Current oncology (Toronto, Ont.)·2026
Same author

The Impact of Malnutrition on Post-Operative Complications in Patients with Ovarian Cancer: A NSQIP Study.

Current oncology (Toronto, Ont.)·2026
Same author

Should lymph node staging be tailored according to molecular profile in endometrial cancer?

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Applying the health belief model to explore healthcare provider and patient perspectives on homologous recombination deficiency testing in cancer: A narrative review.

Cancer treatment and research communications·2026
Same author

Acceptance of weight loss medication in patients with atypical hyperplasia or carcinoma of the endometrium as part of the fertility preservation treatment: A qualitative study.

Gynecologic oncology reports·2026

Related Experiment Video

Updated: Oct 2, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.9K

Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.

Lina Salman1,2, Maria C Cusimano1,2, Zibi Marchocki1,2

  • 1Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Toronto, 610 University Ave, Toronto, ON M5G2M9, Canada.

Current Oncology (Toronto, Ont.)
|February 24, 2022
PubMed
Summary

Sentinel lymph node (SLN) mapping is an accurate alternative to full lymphadenectomy for staging early endometrial cancer (EC). This approach provides prognostic information while reducing surgical morbidity, especially in high-grade cases.

Keywords:
endometrial cancerhigh-gradesentinel lymph node

More Related Videos

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.4K
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

20.1K

Related Experiment Videos

Last Updated: Oct 2, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.9K
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.4K
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

20.1K

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology
  • Pathology

Background:

  • Sentinel lymph node (SLN) mapping is an emerging alternative to full lymphadenectomy for staging clinical stage I endometrial cancer (EC).
  • The therapeutic value of full lymphadenectomy in EC is debated due to low rates of lymph node involvement in most patients.
  • SLN mapping offers prognostic insights while mitigating the morbidity of extensive lymphadenectomy.

Purpose of the Study:

  • To evaluate the role and accuracy of SLN mapping in the surgical staging of endometrial cancer, particularly high-grade subtypes.
  • To compare the benefits of SLN mapping against traditional full lymphadenectomy in EC management.
  • To highlight the need for further prospective data on long-term outcomes following SLN mapping in high-grade EC.

Main Methods:

  • Review of existing studies on SLN mapping accuracy in endometrial cancer.
  • Analysis of detection rates for SLN mapping in high-grade EC.
  • Assessment of prognostic information provided by SLN mapping versus full lymphadenectomy.

Main Results:

  • SLN mapping demonstrates a high detection rate (over 90%) in high-grade EC.
  • The procedure provides crucial prognostic information for tailoring adjuvant treatment.
  • SLN mapping avoids unnecessary morbidity associated with extensive lymphadenectomy in patients without nodal metastasis.

Conclusions:

  • SLN mapping is a validated and accurate method for surgical staging in EC.
  • The approach is particularly beneficial for high-grade EC, where lymph node metastasis risk is significant.
  • Further prospective studies are required to establish long-term oncologic outcomes for SLN mapping in high-grade EC.